Literature DB >> 20164539

Diffusion Weighted Magnetic Resonance Imaging of metastatic bone disease: A biomarker for treatment response monitoring.

C Messiou1, N M deSouza.   

Abstract

Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) combined with conventional MRI can provide a whole body assessment of metastatic bone disease, improved lesion detection compared to other imaging techniques and a direct quantitative assessment of treatment response. In bone marrow, the presence of fat and bone trabeculae and their changing contributions with disease progression and response to treatment present unique challenges for data acquisition and image interpretation. This article discusses these challenges and reviews the potential of DW-MRI to provide a biomarker of response in metastatic bone disease.

Entities:  

Mesh：

Year:  2010        PMID： 20164539     DOI： 10.3233/CBM-2009-0116

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN： 1574-0153            Impact factor:   4.388


  7 in total

1.  Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility.

Authors:  C Messiou; D J Collins; V A Morgan; N M Desouza
Journal:  Eur Radiol       Date:  2011-04-07       Impact factor: 5.315

Review 2.  Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.

Authors:  Julie C Dutoit; Koenraad L Verstraete
Journal:  Skeletal Radiol       Date:  2017-03-13       Impact factor: 2.199

3.  Use of apparent diffusion coefficient as a response biomarker in bone: effect of developing sclerosis on quantified values.

Authors:  C Messiou; D J Collins; V A Morgan; D Bianchini; J S de Bono; N M de Souza
Journal:  Skeletal Radiol       Date:  2013-11-24       Impact factor: 2.199

Review 4.  Bony metastases: assessing response to therapy with whole-body diffusion MRI.

Authors:  A R Padhani; A Gogbashian
Journal:  Cancer Imaging       Date:  2011-10-03       Impact factor: 3.909

5.  [Diffusion-weighted imaging for assessment of lung cancer response to chemotherapy].

Authors:  Rongchao Zhou; Tielian Yu; Changchao Feng; Li Ma; Yan Wang; Weidong Li; Ying Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-03

6.  Differentiation of multiple myeloma and metastases: Use of axial diffusion-weighted MR imaging in addition to standard MR imaging at 3T.

Authors:  Ga Eun Park; Won-Hee Jee; So-Yeon Lee; Jin-Kyeong Sung; Joon-Yong Jung; Robert Grimm; Yohan Son; Mun Young Paek; Chang-Kee Min; Kee-Yong Ha
Journal:  PLoS One       Date:  2018-12-17       Impact factor: 3.240

7.  Whole Body MRI at 3T with Quantitative Diffusion Weighted Imaging and Contrast-Enhanced Sequences for the Characterization of Peripheral Lesions in Patients with Neurofibromatosis Type 2 and Schwannomatosis.

Authors:  Laura M Fayad; Jaishri Blakeley; Scott Plotkin; Brigitte Widemann; Michael A Jacobs
Journal:  ISRN Radiol       Date:  2013-10-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.